SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.093
EU - Europa 6.559
AS - Asia 4.065
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 3
Totale 28.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.074
CN - Cina 2.136
IT - Italia 2.072
UA - Ucraina 1.408
DE - Germania 1.229
TR - Turchia 1.007
SG - Singapore 719
GB - Regno Unito 526
SE - Svezia 440
FI - Finlandia 319
PL - Polonia 174
RU - Federazione Russa 150
FR - Francia 107
HK - Hong Kong 71
ID - Indonesia 63
BE - Belgio 31
CZ - Repubblica Ceca 27
NL - Olanda 27
ES - Italia 18
CA - Canada 15
VN - Vietnam 15
IR - Iran 13
IN - India 12
EU - Europa 7
AU - Australia 6
CL - Cile 6
JP - Giappone 6
RO - Romania 5
AT - Austria 4
CH - Svizzera 4
KR - Corea 4
MX - Messico 4
DZ - Algeria 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
MY - Malesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BR - Brasile 2
GR - Grecia 2
IE - Irlanda 2
IM - Isola di Man 2
IQ - Iraq 2
SA - Arabia Saudita 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
Totale 28.748
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.407
Fairfield 2.035
Jacksonville 1.584
Chandler 1.580
Houston 1.466
Ann Arbor 1.187
Ashburn 1.048
Wilmington 861
Seattle 820
Cambridge 670
Izmir 516
Singapore 509
Nanjing 488
Beijing 399
Princeton 361
Boardman 291
Ferrara 275
Milan 272
Shanghai 183
San Diego 172
Nanchang 165
Warsaw 154
Shenyang 151
Dearborn 149
Los Angeles 124
Addison 111
Bremen 104
Hebei 98
Tianjin 95
Changsha 93
New York 93
Santa Clara 87
Jiaxing 72
Hong Kong 70
Rome 64
Jakarta 63
San Mateo 60
Jinan 57
Norwalk 55
Mountain View 51
Zhengzhou 47
Florence 46
Kunming 46
Falls Church 43
Orange 36
Auburn Hills 35
Düsseldorf 35
Redwood City 35
Ningbo 31
Brussels 30
London 30
Guangzhou 29
Bologna 28
Chicago 24
Philadelphia 24
Washington 24
Verona 23
Des Moines 21
Lanzhou 20
Napoli 19
Taizhou 19
Tappahannock 19
Torino 18
Helsinki 17
Indiana 17
Naples 17
Hefei 16
Brno 15
Hangzhou 15
Bari 14
Catania 14
Dong Ket 14
Munich 14
Camerino 13
Padova 13
Ferrara di Monte Baldo 12
Haikou 12
Redmond 12
Augusta 11
Kilburn 11
Livorno 11
Cagliari 9
Meppel 9
Olomouc 9
Otura 9
Bergamo 7
Caserta 7
Reggio Emilia 7
Reggio Nell'emilia 7
Ardabil 6
Aversa 6
Foggia 6
Genoa 6
Hounslow 6
Monmouth Junction 6
Montebelluna 6
Palermo 6
Parma 6
Salerno 6
Changchun 5
Totale 20.099
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.146
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 276
A glance at adenosine receptors: Novel target for antitumor therapy 196
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 192
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 192
The A3 adenosine receptor: history and perspectives 164
Pharmacology of Adenosine Receptors: The State of the Art 157
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 156
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 155
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 154
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 151
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 149
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 148
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 146
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 144
Pathological overproduction: the bad side of adenosine 143
Adenosine receptors and human melanoma 140
Adenosine receptor targeting in health and disease 136
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 135
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 134
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 132
Therapeutic potential of adenosine receptor antagonists and agonists 132
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 132
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 128
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 128
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 127
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 126
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 124
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 124
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 124
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 124
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 122
Adenosine receptors and cancer 122
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 122
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 122
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 121
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 121
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 120
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 120
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 120
Binding thermodynamics at A1 and A2A adenosine receptors 118
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 118
null 118
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 116
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 116
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 116
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 115
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 115
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 115
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 115
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 114
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 114
New potent and selective human adenosine A3 receptor antagonists. 114
The A3 adenosine receptor: an enigmatic player in cell biology. 113
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 113
null 113
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 113
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 112
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 112
null 112
Agonists and antagonists: Molecular mechanisms and therapeutic applications 112
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 111
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 111
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 110
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 110
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 109
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 109
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
Adenosine and lymphocyte regulation 109
A(2A) adenosine receptors in human peripheral blood cells 108
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 107
null 107
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 107
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 107
Adenosine receptors in health and disease 107
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 106
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 106
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 106
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 106
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 106
van't Hoff Based Thermodynamics 106
null 106
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 105
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 105
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 105
The P2X7 receptor as a therapeutic target. 104
Synthesis, molecular modeling and opioid receptor affinity of 9,10-diazatricyclo[4.2.1.1 2,5]decanes and 2,7-diazatricyclo[4.4.0.0 3,8]decanes structurally related to 3,8-diazabicyclo[3.2.1]octanes 104
Adenosine A2A receptors in human circulating blood elements 103
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 103
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 103
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 102
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 102
null 102
Binding thermodynamics of 5-HT(1A) receptor ligands 102
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 102
null 102
Adenosine receptors and cancer 102
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 101
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells 100
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 100
Totale 13.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.498
Totale 124.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.336 0 0 143 746 318 659 484 550 414 647 281 94
2020/20214.151 397 431 173 487 220 445 145 471 76 563 511 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/2025989 188 220 581 0 0 0 0 0 0 0 0 0
Totale 29.138